Browsing: Wellness Tips

Investing.com — Eli Lilly announced Thursday it will file for approval of its next-generation obesity drug retatrutide in the first quarter of 2027, pushing back from an earlier timeline that targeted this year. The pharmaceutical company said it needs additional time to collect and verify manufacturing and quality-control data required by regulators

This is a paid press release. Contact the press release distributor directly with any inquiries.

In today’s Pharmaceutical Executive Daily, Eli Lilly’s Retatrutide delivers up to 22.6% weight loss in two new Phase III trials, a clinical trial expert discusses why the U.S. is losing trial volume to Australia and China, and a pharmacy benefits executive weighs in on why short-term cost thinking is complicating GLP-1 coverage decisions

People taking popular GLP-1 medications such as Ozempic, Wegovy and Mounjaro may face a higher risk of hair loss than patients using other diabetes drugs, according to a new study published in The British Medical Journal

Eli Lilly (LLY, Financials), a pharmaceutical firm that focuses on diabetes, obesity and other chronic diseases, said it aims to petition for regulatory approval of retatrutide in the first quarter of 2027 after the medicine succeeded in two more phase 3 trials

Novo Nordisk has sued Eli Lilly over national advertising campaigns for the companies’ competing weight loss and diabetes drugs, alleging that Lilly is misleading consumers by using older clinical trials to claim its treatments are more effective

The Indian Council of Medical Research–National Institute of Nutrition (ICMR-NIN)-led ‘Let’s Fix Our Food’ (LFOF) Consortium released a policy document titled ‘Priority policy actions to promote healthier diets and food environments for children and adolescents in India’, on July 22.​India is facing a rapidly growing burden of diet-related non-communicable diseases (NCDs), including obesity, diabetes, hypertension,…

Dr Adam Staten, 43, works alongside patients losing weight through GLP1 medications – prescription drugs that work to regulate blood sugar and curb appetite. He said people expected the roll out of tablet Ozempic to “change the landscape of weight management”. The GP and medical director for One Day Tests said the team anticipated a…

Overweight or obese diabetes patients had 20.8% weight loss at high dose of retatrutide

Lilly said it plans to submit a Biologics License Application to the U.S. Food and Drug Administration in the first quarter of 2027